Effect of a very low-carbohydrate ketogenic diet vs recommended diets in patients with type 2 diabetes: a meta-analysis
- PMID: 34338787
- DOI: 10.1093/nutrit/nuab040
Effect of a very low-carbohydrate ketogenic diet vs recommended diets in patients with type 2 diabetes: a meta-analysis
Abstract
Context: There is renewed interest in using very low-carbohydrate ketogenic (VLCK) diets to manage diabetes. Many clinical trials have been published, often with mixed results.
Objective: This meta-analysis compares the effect of a VLCK diet on glycemic control, body weight, lipid profile, medication use, and dropouts with that of recommended diets for 12 weeks or longer in people with type 2 diabetes.
Data sources: Ovid MEDLINE, Ovid Embase, CENTRAL, and CINAHL databases were searched (January 1980 through September 2019).
Study selection: Two authors independently reviewed search results to select randomized controlled trials (RCTs) comparing a VLCK diet (carbohydrate intake < 50 g/d or < 10% of total energy) with any recommended diet for type 2 diabetes in adults. Discrepancies were resolved after consulting with the third author.
Data extraction: Eight RCTs with 648 participants were identified.
Results: Compared with control diets, the VLCK diet resulted in a greater decrease in hemoglobin A1c after 3 months (weighted mean difference[WMD]: -6.7 mmol/mol; 95%CI, -9.0 to -4.4) (WMD: -0.61%; 95%CI, -0.82 to -0.40; P < 0.001; moderate-certainty evidence) and after 6 months (WMD: -6.3 mmol/mol; 95%CI, -9.3 to -3.5) (WMD: -0.58%; 95%CI, -0.85 to -0.32; low-certainty evidence). There was a significantly greater weight loss with the VLCK diet after 3 months (WMD: -2.91 kg; 95%CI, -4.88 to -0.95; low-certainty evidence) and after 6 months (WMD: -2.84 kg; 95%CI, -5.29 to -0.39; low-certainty evidence). The VLCK diet was not better than a control diet after 12 months. It was superior in decreasing triglyceride levels, increasing high-density lipoprotein cholesterol levels, and reducing the use of antidiabetic medications for up to 12 months.
Conclusion: The VLCK diet appears to control glycemia and decrease body weight for up to 6 months in people with obesity and diabetes. Beneficial changes in serum triglycerides and high-density lipoprotein cholesterol, along with reductions in antidiabetic medications, continued in the VLCK group until 12 months. However, the quality of currently available evidence is not sufficient to recommend VLCK diets. A major limitation of the VLCK diet is patients' lack of adherence to carbohydrate restriction.
Systematic review registration: PROSPERO registration number CRD42020154700.
Keywords: HbA1c; T2D; VLCK; carbohydrate-restricted; diabetes; diet; ketogenic; low-carbohydrate.
© The Author(s) 2021. Published by Oxford University Press on behalf of the International Life Sciences Institute. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Similar articles
-
Effect of Dietary Approaches on Glycemic Control in Patients with Type 2 Diabetes: A Systematic Review with Network Meta-Analysis of Randomized Trials.Nutrients. 2023 Jul 15;15(14):3156. doi: 10.3390/nu15143156. Nutrients. 2023. PMID: 37513574 Free PMC article. Review.
-
Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission.Diabetologia. 2022 Jan;65(1):14-36. doi: 10.1007/s00125-021-05577-2. Epub 2021 Nov 17. Diabetologia. 2022. PMID: 34796367 Free PMC article. Review.
-
Efficacy and safety of low and very low carbohydrate diets for type 2 diabetes remission: systematic review and meta-analysis of published and unpublished randomized trial data.BMJ. 2021 Jan 13;372:m4743. doi: 10.1136/bmj.m4743. BMJ. 2021. PMID: 33441384 Free PMC article.
-
Ketogenic diets for drug-resistant epilepsy.Cochrane Database Syst Rev. 2020 Jun 24;6(6):CD001903. doi: 10.1002/14651858.CD001903.pub5. Cochrane Database Syst Rev. 2020. PMID: 32588435 Free PMC article.
-
Short-term safety, tolerability and efficacy of a very low-calorie-ketogenic diet interventional weight loss program versus hypocaloric diet in patients with type 2 diabetes mellitus.Nutr Diabetes. 2016 Sep 19;6(9):e230. doi: 10.1038/nutd.2016.36. Nutr Diabetes. 2016. PMID: 27643725 Free PMC article. Clinical Trial.
Cited by
-
Nutritional therapy bridges the critical cut-off point for the closed-loop role of type 2 diabetes and bone homeostasis: A narrative review.Heliyon. 2024 Mar 22;10(7):e28229. doi: 10.1016/j.heliyon.2024.e28229. eCollection 2024 Apr 15. Heliyon. 2024. PMID: 38689978 Free PMC article. Review.
-
Methodological Challenges and Confounders in Research on the Effects of Ketogenic Diets: A Literature Review of Meta-Analyses.Foods. 2024 Jan 12;13(2):248. doi: 10.3390/foods13020248. Foods. 2024. PMID: 38254549 Free PMC article. Review.
-
Risks of the ketogenic diet in CKD - the con part.Clin Kidney J. 2023 Nov 7;17(1):sfad274. doi: 10.1093/ckj/sfad274. eCollection 2024 Jan. Clin Kidney J. 2023. PMID: 38186877 Free PMC article. Review.
-
Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations.Diabetes Metab Syndr Obes. 2023 Nov 16;16:3669-3689. doi: 10.2147/DMSO.S390752. eCollection 2023. Diabetes Metab Syndr Obes. 2023. PMID: 38028995 Free PMC article. Review.
-
Diet in the management of type 2 diabetes: umbrella review of systematic reviews with meta-analyses of randomised controlled trials.BMJ Med. 2023 Nov 9;2(1):e000664. doi: 10.1136/bmjmed-2023-000664. eCollection 2023. BMJ Med. 2023. PMID: 38027413 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical